Charles River Laboratories International, Inc.
CRL
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufactuā¦ read more
Healthcare
Diagnostics & Research
25 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$215.51
Price-0.58%
-$1.26
1Y
Price
Market Cap
$10.606b
Large
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+19.7%
EBITDA Margin+5.4%
Net Profit Margin+17.7%
Free Cash Flow Margin+19.7%
EBITDA Margin+5.4%
Net Profit Margin+17.7%
Free Cash Flow MarginRevenue
$4.024b
-0.6%
1y CAGR+0.4%
3y CAGR+3.4%
5y CAGREarnings
-$83.482m
-910.7%
1y CAGR-337.0%
3y CAGR-246.6%
5y CAGREPS
-$1.56
-880.0%
1y CAGR-326.9%
3y CAGR-239.0%
5y CAGRBook Value
$3.451b
$7.514b
Assets$4.063b
Liabilities$2.631b
DebtDebt to Assets
35.0%
5.1x
Debt to EBITDAFree Cash Flow
$543.670m
+8.4%
1y CAGR+23.2%
3y CAGR+6.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company